2015
DOI: 10.1093/ecco-jcc/jjv050
|View full text |Cite
|
Sign up to set email alerts
|

High-Resolution Gene Expression Profiling Using RNA Sequencing in Patients With Inflammatory Bowel Disease and in Mouse Models of Colitis

Abstract: IBD and experimental murine colitis have a high degree of similarity in the colonic transcriptional profile, probably secondary to non-specific inflammatory processes. However, differences do exist between models, emphasising the need for careful selection and interpretation of qualified animal models in preclinical research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
66
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 61 publications
(70 citation statements)
references
References 79 publications
4
66
0
Order By: Relevance
“…Given that the PanCancer Immune Profiling probe set captures expression data for up to 750 genes, we sought to compare the transcriptional profiles for our TWD-exposed mice during colitis to other available datasets in animal models and human UC patients. Our comparison focused primarily on those studies using genome-wide methodologies including a genome-wide microarray study of mouse colon mucosa collected after 6 days exposure to 3% DSS [66], RNAseq analysis of colon mucosa collected after exposure to 4% DSS (5 days treatment, with collection on day 8) [67], RNAseq analysis of colon mucosa from the PAC-Il10 -/mouse model compared to wildtype [67], a microarray study of colon tissue samples from human UC patients compared to healthy controls [68], and an RNAseq assessment of colon tissues from human UC patients versus healthy controls [67]. (We note that other reports also employed genome-wide analyses to examine the colon transcriptome in DSS or IL-deficient mice, although the complete results or underlying data were not publicly available for us to use in this comparative analysis).…”
Section: Discussionmentioning
confidence: 99%
“…Given that the PanCancer Immune Profiling probe set captures expression data for up to 750 genes, we sought to compare the transcriptional profiles for our TWD-exposed mice during colitis to other available datasets in animal models and human UC patients. Our comparison focused primarily on those studies using genome-wide methodologies including a genome-wide microarray study of mouse colon mucosa collected after 6 days exposure to 3% DSS [66], RNAseq analysis of colon mucosa collected after exposure to 4% DSS (5 days treatment, with collection on day 8) [67], RNAseq analysis of colon mucosa from the PAC-Il10 -/mouse model compared to wildtype [67], a microarray study of colon tissue samples from human UC patients compared to healthy controls [68], and an RNAseq assessment of colon tissues from human UC patients versus healthy controls [67]. (We note that other reports also employed genome-wide analyses to examine the colon transcriptome in DSS or IL-deficient mice, although the complete results or underlying data were not publicly available for us to use in this comparative analysis).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, we expected to observe upregulation of collagen proteins and hydroxyproline-containing peptides. Indeed, increases in collagen transcripts were found with all 3 previously published transcriptomics datasets (28,30,58).…”
Section: Discussionmentioning
confidence: 60%
“…RNA sequencing has been used to identify genomic mutations such as fusion transcripts in colon cancer[14], as well as the pathogenesis of colorectal cancer[15,16]. Attempts to discover a unique transcript marker for colorectal cancer[17,18] and inflammatory bowel disease have also been attempted for quicker diagnosis than current screening methods[19,20]. RNA sequencing has also been used to investigate treatment response for rectal cancer[21].…”
Section: Colorectal Disease and Rna Sequencingmentioning
confidence: 99%